Cipla's R&D investment share FY 2014-2022

Published by
Sanyukta Kanwal,
Jan 3, 2023
The share of investments in research and development of new drugs made by Cipla India during fiscal year 2022 was over five percent of their overall revenue. This was a slight decrease in the share allotted for research compared to the previous fiscal year. Fiscal year 2017 saw an investment of eight percent, the highest since 2014.

Share of investment in research and development at Cipla Limited from financial year 2014 to 2022

© Statista 2023
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

August 2022

Region

India

Survey time period

FY 2014 to FY 2022

Supplementary notes

India's financial year begins in April and ends in March. For example, FY 2020 started in April 2019 and ended in March 2020.

One Indian rupee is equal to 0.012 euros and 0.014 dollars as of January 2023.

Citation formats
Statista Accounts: Access All Statistics. Starting from $468 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 USD $39 USD / Month *
in the first 12 months
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " Pharmaceutical brands: Cymbalta (Eli Lilly) "

The most important statistics
The most important statistics
The most important statistics

Statistics on Pharmaceutical brands: Cymbalta (Eli Lilly)

Overview

4

Drug prices and consumer behavior

4

Advertising expenditures

4

Further related statistics

20

Further Content: You might find this interesting as well

Statistics

Topics

Biotechnology in SpainGlobal pharmaceutical industryBiotech drugsBiotechnology industry in Germany Biotechnology in Europe
Statista Accounts: Access All Statistics. Starting from $468 USD / Year
Learn more about how Statista can support your business.
Menu